In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Applied DNA Sciences (APDN), with a price target of $12.00. The company’s shares closed last Tuesday at $5.27.
According to TipRanks.com, Chen is a 5-star analyst with an average return of 55.2% and a 47.4% success rate. Chen covers the Healthcare sector, focusing on stocks such as Interpace Diagnostics Group, HTG Molecular Diagnostics, and EyePoint Pharmaceuticals.
Applied DNA Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $13.50, representing a 152.3% upside. In a report issued on December 18, Maxim Group also reiterated a Buy rating on the stock with a $15.00 price target.
See today’s analyst top recommended stocks >>
Applied DNA Sciences’ market cap is currently $29.84M and has a P/E ratio of -1.50. The company has a Price to Book ratio of 6.05.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.
